nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—ABCB1—Lisinopril—dilated cardiomyopathy	0.125	0.532	CbGbCtD
Fluvoxamine—ABCB1—Spironolactone—dilated cardiomyopathy	0.11	0.468	CbGbCtD
Fluvoxamine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.0038	0.00498	CcSEcCtD
Fluvoxamine—Mental disability—Furosemide—dilated cardiomyopathy	0.00377	0.00495	CcSEcCtD
Fluvoxamine—Breast pain—Lisinopril—dilated cardiomyopathy	0.00374	0.0049	CcSEcCtD
Fluvoxamine—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00369	0.00484	CcSEcCtD
Fluvoxamine—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00363	0.00476	CcSEcCtD
Fluvoxamine—Viral infection—Lisinopril—dilated cardiomyopathy	0.00361	0.00474	CcSEcCtD
Fluvoxamine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.0036	0.00471	CcSEcCtD
Fluvoxamine—Polyuria—Furosemide—dilated cardiomyopathy	0.0036	0.00471	CcSEcCtD
Fluvoxamine—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00359	0.0047	CcSEcCtD
Fluvoxamine—Cough increased—Lisinopril—dilated cardiomyopathy	0.00356	0.00467	CcSEcCtD
Fluvoxamine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00355	0.00465	CcSEcCtD
Fluvoxamine—Oliguria—Lisinopril—dilated cardiomyopathy	0.00354	0.00464	CcSEcCtD
Fluvoxamine—Deafness—Furosemide—dilated cardiomyopathy	0.00353	0.00463	CcSEcCtD
Fluvoxamine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00353	0.00463	CcSEcCtD
Fluvoxamine—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00352	0.00461	CcSEcCtD
Fluvoxamine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00347	0.00455	CcSEcCtD
Fluvoxamine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00336	0.0044	CcSEcCtD
Fluvoxamine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00335	0.00439	CcSEcCtD
Fluvoxamine—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00334	0.00438	CcSEcCtD
Fluvoxamine—Thirst—Furosemide—dilated cardiomyopathy	0.00332	0.00435	CcSEcCtD
Fluvoxamine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.0033	0.00433	CcSEcCtD
Fluvoxamine—Neck pain—Lisinopril—dilated cardiomyopathy	0.0033	0.00433	CcSEcCtD
Fluvoxamine—Purpura—Furosemide—dilated cardiomyopathy	0.00328	0.00429	CcSEcCtD
Fluvoxamine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00326	0.00428	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00324	0.00425	CcSEcCtD
Fluvoxamine—Lethargy—Furosemide—dilated cardiomyopathy	0.00322	0.00422	CcSEcCtD
Fluvoxamine—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00319	0.00418	CcSEcCtD
Fluvoxamine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00317	0.00416	CcSEcCtD
Fluvoxamine—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00317	0.00415	CcSEcCtD
Fluvoxamine—Malaise—Spironolactone—dilated cardiomyopathy	0.00315	0.00413	CcSEcCtD
Fluvoxamine—Cystitis—Lisinopril—dilated cardiomyopathy	0.00315	0.00413	CcSEcCtD
Fluvoxamine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00313	0.0041	CcSEcCtD
Fluvoxamine—Photophobia—Lisinopril—dilated cardiomyopathy	0.00306	0.00402	CcSEcCtD
Fluvoxamine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00306	0.00402	CcSEcCtD
Fluvoxamine—Irritability—Furosemide—dilated cardiomyopathy	0.00301	0.00395	CcSEcCtD
Fluvoxamine—Urinary retention—Furosemide—dilated cardiomyopathy	0.003	0.00394	CcSEcCtD
Fluvoxamine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00295	0.00387	CcSEcCtD
Fluvoxamine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00294	0.00385	CcSEcCtD
Fluvoxamine—Dehydration—Furosemide—dilated cardiomyopathy	0.00294	0.00385	CcSEcCtD
Fluvoxamine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00288	0.00378	CcSEcCtD
Fluvoxamine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00288	0.00377	CcSEcCtD
Fluvoxamine—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00287	0.00377	CcSEcCtD
Fluvoxamine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00286	0.00375	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00285	0.00374	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00284	0.00373	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00279	0.00366	CcSEcCtD
Fluvoxamine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00278	0.00365	CcSEcCtD
Fluvoxamine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00275	0.0036	CcSEcCtD
Fluvoxamine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00274	0.00359	CcSEcCtD
Fluvoxamine—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00272	0.00357	CcSEcCtD
Fluvoxamine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00271	0.00355	CcSEcCtD
Fluvoxamine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.0027	0.00354	CcSEcCtD
Fluvoxamine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00268	0.00351	CcSEcCtD
Fluvoxamine—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00267	0.0035	CcSEcCtD
Fluvoxamine—Eczema—Lisinopril—dilated cardiomyopathy	0.00264	0.00346	CcSEcCtD
Fluvoxamine—Injury—Lisinopril—dilated cardiomyopathy	0.00258	0.00338	CcSEcCtD
Fluvoxamine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00257	0.00336	CcSEcCtD
Fluvoxamine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00255	0.00335	CcSEcCtD
Fluvoxamine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00254	0.00332	CcSEcCtD
Fluvoxamine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00252	0.0033	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00249	0.00327	CcSEcCtD
Fluvoxamine—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00249	0.00326	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00246	0.00323	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00246	0.00323	CcSEcCtD
Fluvoxamine—Arthritis—Lisinopril—dilated cardiomyopathy	0.00244	0.0032	CcSEcCtD
Fluvoxamine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00243	0.00319	CcSEcCtD
Fluvoxamine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00243	0.00318	CcSEcCtD
Fluvoxamine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00242	0.00317	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00241	0.00316	CcSEcCtD
Fluvoxamine—Renal failure—Furosemide—dilated cardiomyopathy	0.00239	0.00314	CcSEcCtD
Fluvoxamine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00238	0.00312	CcSEcCtD
Fluvoxamine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00237	0.00311	CcSEcCtD
Fluvoxamine—Diplopia—Lisinopril—dilated cardiomyopathy	0.00237	0.00311	CcSEcCtD
Fluvoxamine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00235	0.00308	CcSEcCtD
Fluvoxamine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00235	0.00308	CcSEcCtD
Fluvoxamine—Sweating—Furosemide—dilated cardiomyopathy	0.00233	0.00306	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.0023	0.00302	CcSEcCtD
Fluvoxamine—Face oedema—Lisinopril—dilated cardiomyopathy	0.00229	0.003	CcSEcCtD
Fluvoxamine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00227	0.00298	CcSEcCtD
Fluvoxamine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00227	0.00297	CcSEcCtD
Fluvoxamine—Irritability—Lisinopril—dilated cardiomyopathy	0.00226	0.00296	CcSEcCtD
Fluvoxamine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00225	0.00296	CcSEcCtD
Fluvoxamine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00225	0.00295	CcSEcCtD
Fluvoxamine—Ataxia—Lisinopril—dilated cardiomyopathy	0.00223	0.00292	CcSEcCtD
Fluvoxamine—Dehydration—Lisinopril—dilated cardiomyopathy	0.0022	0.00289	CcSEcCtD
Fluvoxamine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00216	0.00284	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00216	0.00283	CcSEcCtD
Fluvoxamine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00214	0.00281	CcSEcCtD
Fluvoxamine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00214	0.00281	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00213	0.0028	CcSEcCtD
Fluvoxamine—Visual impairment—Furosemide—dilated cardiomyopathy	0.0021	0.00276	CcSEcCtD
Fluvoxamine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0021	0.00275	CcSEcCtD
Fluvoxamine—Gastritis—Lisinopril—dilated cardiomyopathy	0.0021	0.00275	CcSEcCtD
Fluvoxamine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00207	0.00271	CcSEcCtD
Fluvoxamine—Asthma—Lisinopril—dilated cardiomyopathy	0.00205	0.00268	CcSEcCtD
Fluvoxamine—Influenza—Lisinopril—dilated cardiomyopathy	0.00205	0.00268	CcSEcCtD
Fluvoxamine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00204	0.00268	CcSEcCtD
Fluvoxamine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00204	0.00267	CcSEcCtD
Fluvoxamine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00202	0.00265	CcSEcCtD
Fluvoxamine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00201	0.00263	CcSEcCtD
Fluvoxamine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00199	0.00261	CcSEcCtD
Fluvoxamine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00199	0.00261	CcSEcCtD
Fluvoxamine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00198	0.0026	CcSEcCtD
Fluvoxamine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00197	0.00258	CcSEcCtD
Fluvoxamine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00195	0.00256	CcSEcCtD
Fluvoxamine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00195	0.00256	CcSEcCtD
Fluvoxamine—Dysuria—Lisinopril—dilated cardiomyopathy	0.00191	0.00251	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.0019	0.00249	CcSEcCtD
Fluvoxamine—Malnutrition—Furosemide—dilated cardiomyopathy	0.0019	0.00249	CcSEcCtD
Fluvoxamine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00189	0.00247	CcSEcCtD
Fluvoxamine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00189	0.00247	CcSEcCtD
Fluvoxamine—Flatulence—Furosemide—dilated cardiomyopathy	0.00187	0.00246	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00187	0.00245	CcSEcCtD
Fluvoxamine—Weight increased—Lisinopril—dilated cardiomyopathy	0.00186	0.00244	CcSEcCtD
Fluvoxamine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00186	0.00244	CcSEcCtD
Fluvoxamine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00185	0.00243	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00185	0.00242	CcSEcCtD
Fluvoxamine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00184	0.00241	CcSEcCtD
Fluvoxamine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00183	0.0024	CcSEcCtD
Fluvoxamine—Depression—Lisinopril—dilated cardiomyopathy	0.00182	0.00239	CcSEcCtD
Fluvoxamine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00181	0.00238	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00181	0.00237	CcSEcCtD
Fluvoxamine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.0018	0.00236	CcSEcCtD
Fluvoxamine—Rash—Spironolactone—dilated cardiomyopathy	0.0018	0.00236	CcSEcCtD
Fluvoxamine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0018	0.00236	CcSEcCtD
Fluvoxamine—Renal failure—Lisinopril—dilated cardiomyopathy	0.00179	0.00235	CcSEcCtD
Fluvoxamine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00179	0.00235	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00179	0.00235	CcSEcCtD
Fluvoxamine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00179	0.00235	CcSEcCtD
Fluvoxamine—Headache—Spironolactone—dilated cardiomyopathy	0.00179	0.00234	CcSEcCtD
Fluvoxamine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00178	0.00233	CcSEcCtD
Fluvoxamine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00177	0.00233	CcSEcCtD
Fluvoxamine—Anaemia—Furosemide—dilated cardiomyopathy	0.00176	0.0023	CcSEcCtD
Fluvoxamine—Sweating—Lisinopril—dilated cardiomyopathy	0.00175	0.00229	CcSEcCtD
Fluvoxamine—Agitation—Furosemide—dilated cardiomyopathy	0.00175	0.00229	CcSEcCtD
Fluvoxamine—Haematuria—Lisinopril—dilated cardiomyopathy	0.00174	0.00228	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00173	0.00226	CcSEcCtD
Fluvoxamine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00172	0.00226	CcSEcCtD
Fluvoxamine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00171	0.00225	CcSEcCtD
Fluvoxamine—Vertigo—Furosemide—dilated cardiomyopathy	0.00171	0.00224	CcSEcCtD
Fluvoxamine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.0017	0.00223	CcSEcCtD
Fluvoxamine—Leukopenia—Furosemide—dilated cardiomyopathy	0.0017	0.00223	CcSEcCtD
Fluvoxamine—Nausea—Spironolactone—dilated cardiomyopathy	0.00169	0.00222	CcSEcCtD
Fluvoxamine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00167	0.00219	CcSEcCtD
Fluvoxamine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00164	0.00215	CcSEcCtD
Fluvoxamine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00164	0.00215	CcSEcCtD
Fluvoxamine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00163	0.00214	CcSEcCtD
Fluvoxamine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00163	0.00213	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00162	0.00212	CcSEcCtD
Fluvoxamine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00161	0.00212	CcSEcCtD
Fluvoxamine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00161	0.00211	CcSEcCtD
Fluvoxamine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00158	0.00208	CcSEcCtD
Fluvoxamine—Confusional state—Furosemide—dilated cardiomyopathy	0.00156	0.00205	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00155	0.00203	CcSEcCtD
Fluvoxamine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00155	0.00203	CcSEcCtD
Fluvoxamine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00153	0.002	CcSEcCtD
Fluvoxamine—Shock—Furosemide—dilated cardiomyopathy	0.00153	0.002	CcSEcCtD
Fluvoxamine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00152	0.00199	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00152	0.00199	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.0015	0.00197	CcSEcCtD
Fluvoxamine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00149	0.00195	CcSEcCtD
Fluvoxamine—Anorexia—Furosemide—dilated cardiomyopathy	0.00148	0.00194	CcSEcCtD
Fluvoxamine—Chills—Lisinopril—dilated cardiomyopathy	0.00147	0.00193	CcSEcCtD
Fluvoxamine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00146	0.00192	CcSEcCtD
Fluvoxamine—Hypotension—Furosemide—dilated cardiomyopathy	0.00145	0.0019	CcSEcCtD
Fluvoxamine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00145	0.0019	CcSEcCtD
Fluvoxamine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00144	0.00188	CcSEcCtD
Fluvoxamine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00143	0.00187	CcSEcCtD
Fluvoxamine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00141	0.00184	CcSEcCtD
Fluvoxamine—Tension—Lisinopril—dilated cardiomyopathy	0.0014	0.00184	CcSEcCtD
Fluvoxamine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.0014	0.00183	CcSEcCtD
Fluvoxamine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00139	0.00183	CcSEcCtD
Fluvoxamine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00139	0.00182	CcSEcCtD
Fluvoxamine—Back pain—Lisinopril—dilated cardiomyopathy	0.00138	0.00181	CcSEcCtD
Fluvoxamine—Somnolence—Furosemide—dilated cardiomyopathy	0.00138	0.00181	CcSEcCtD
Fluvoxamine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00137	0.0018	CcSEcCtD
Fluvoxamine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00135	0.00177	CcSEcCtD
Fluvoxamine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00134	0.00176	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00134	0.00176	CcSEcCtD
Fluvoxamine—Fatigue—Furosemide—dilated cardiomyopathy	0.00134	0.00175	CcSEcCtD
Fluvoxamine—Tremor—Lisinopril—dilated cardiomyopathy	0.00134	0.00175	CcSEcCtD
Fluvoxamine—Pain—Furosemide—dilated cardiomyopathy	0.00133	0.00174	CcSEcCtD
Fluvoxamine—Constipation—Furosemide—dilated cardiomyopathy	0.00133	0.00174	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00132	0.00174	CcSEcCtD
Fluvoxamine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00132	0.00173	CcSEcCtD
Fluvoxamine—Angioedema—Lisinopril—dilated cardiomyopathy	0.0013	0.00171	CcSEcCtD
Fluvoxamine—Malaise—Lisinopril—dilated cardiomyopathy	0.00129	0.00169	CcSEcCtD
Fluvoxamine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00128	0.00168	CcSEcCtD
Fluvoxamine—Syncope—Lisinopril—dilated cardiomyopathy	0.00128	0.00168	CcSEcCtD
Fluvoxamine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00128	0.00168	CcSEcCtD
Fluvoxamine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00128	0.00167	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00127	0.00166	CcSEcCtD
Fluvoxamine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00126	0.00165	CcSEcCtD
Fluvoxamine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00125	0.00164	CcSEcCtD
Fluvoxamine—Cough—Lisinopril—dilated cardiomyopathy	0.00124	0.00163	CcSEcCtD
Fluvoxamine—Urticaria—Furosemide—dilated cardiomyopathy	0.00123	0.00162	CcSEcCtD
Fluvoxamine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00123	0.00161	CcSEcCtD
Fluvoxamine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00123	0.00161	CcSEcCtD
Fluvoxamine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00121	0.00159	CcSEcCtD
Fluvoxamine—Myalgia—Lisinopril—dilated cardiomyopathy	0.00121	0.00159	CcSEcCtD
Fluvoxamine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00121	0.00159	CcSEcCtD
Fluvoxamine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00121	0.00159	CcSEcCtD
Fluvoxamine—Discomfort—Lisinopril—dilated cardiomyopathy	0.0012	0.00157	CcSEcCtD
Fluvoxamine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00119	0.00156	CcSEcCtD
Fluvoxamine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00117	0.00154	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00116	0.00153	CcSEcCtD
Fluvoxamine—Oedema—Lisinopril—dilated cardiomyopathy	0.00116	0.00153	CcSEcCtD
Fluvoxamine—Infection—Lisinopril—dilated cardiomyopathy	0.00116	0.00152	CcSEcCtD
Fluvoxamine—Shock—Lisinopril—dilated cardiomyopathy	0.00115	0.0015	CcSEcCtD
Fluvoxamine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00114	0.0015	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00114	0.00149	CcSEcCtD
Fluvoxamine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00114	0.00149	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00113	0.00148	CcSEcCtD
Fluvoxamine—Asthenia—Furosemide—dilated cardiomyopathy	0.00111	0.00146	CcSEcCtD
Fluvoxamine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00111	0.00145	CcSEcCtD
Fluvoxamine—Pruritus—Furosemide—dilated cardiomyopathy	0.0011	0.00144	CcSEcCtD
Fluvoxamine—CYP2C9—cardial valve—dilated cardiomyopathy	0.00109	0.573	CbGeAlD
Fluvoxamine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00109	0.00143	CcSEcCtD
Fluvoxamine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00106	0.00139	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00106	0.00139	CcSEcCtD
Fluvoxamine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00105	0.00138	CcSEcCtD
Fluvoxamine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00105	0.00137	CcSEcCtD
Fluvoxamine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00104	0.00136	CcSEcCtD
Fluvoxamine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00104	0.00136	CcSEcCtD
Fluvoxamine—Dizziness—Furosemide—dilated cardiomyopathy	0.00103	0.00135	CcSEcCtD
Fluvoxamine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00102	0.00134	CcSEcCtD
Fluvoxamine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00101	0.00133	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00101	0.00132	CcSEcCtD
Fluvoxamine—Fatigue—Lisinopril—dilated cardiomyopathy	0.001	0.00132	CcSEcCtD
Fluvoxamine—Pain—Lisinopril—dilated cardiomyopathy	0.000996	0.00131	CcSEcCtD
Fluvoxamine—Constipation—Lisinopril—dilated cardiomyopathy	0.000996	0.00131	CcSEcCtD
Fluvoxamine—Vomiting—Furosemide—dilated cardiomyopathy	0.000987	0.00129	CcSEcCtD
Fluvoxamine—Rash—Furosemide—dilated cardiomyopathy	0.000978	0.00128	CcSEcCtD
Fluvoxamine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000977	0.00128	CcSEcCtD
Fluvoxamine—Headache—Furosemide—dilated cardiomyopathy	0.000972	0.00127	CcSEcCtD
Fluvoxamine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000959	0.00126	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000952	0.00125	CcSEcCtD
Fluvoxamine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000925	0.00121	CcSEcCtD
Fluvoxamine—Nausea—Furosemide—dilated cardiomyopathy	0.000922	0.00121	CcSEcCtD
Fluvoxamine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00092	0.00121	CcSEcCtD
Fluvoxamine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00092	0.00121	CcSEcCtD
Fluvoxamine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000858	0.00112	CcSEcCtD
Fluvoxamine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000835	0.0011	CcSEcCtD
Fluvoxamine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000824	0.00108	CcSEcCtD
Fluvoxamine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000797	0.00104	CcSEcCtD
Fluvoxamine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00077	0.00101	CcSEcCtD
Fluvoxamine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00074	0.00097	CcSEcCtD
Fluvoxamine—Rash—Lisinopril—dilated cardiomyopathy	0.000734	0.000962	CcSEcCtD
Fluvoxamine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000733	0.000962	CcSEcCtD
Fluvoxamine—Headache—Lisinopril—dilated cardiomyopathy	0.000729	0.000956	CcSEcCtD
Fluvoxamine—Nausea—Lisinopril—dilated cardiomyopathy	0.000692	0.000907	CcSEcCtD
Fluvoxamine—SIGMAR1—cardiac ventricle—dilated cardiomyopathy	0.000142	0.0745	CbGeAlD
Fluvoxamine—SIGMAR1—myocardium—dilated cardiomyopathy	0.000134	0.0701	CbGeAlD
Fluvoxamine—CYP1A1—cardiac ventricle—dilated cardiomyopathy	9.55e-05	0.0501	CbGeAlD
Fluvoxamine—SIGMAR1—heart—dilated cardiomyopathy	9.33e-05	0.0489	CbGeAlD
Fluvoxamine—SIGMAR1—cardiac atrium—dilated cardiomyopathy	7.98e-05	0.0418	CbGeAlD
Fluvoxamine—CYP1A1—heart—dilated cardiomyopathy	6.27e-05	0.0329	CbGeAlD
Fluvoxamine—CYP2B6—heart—dilated cardiomyopathy	6.09e-05	0.032	CbGeAlD
Fluvoxamine—CYP2C9—heart—dilated cardiomyopathy	6.03e-05	0.0316	CbGeAlD
Fluvoxamine—CYP1A1—cardiac atrium—dilated cardiomyopathy	5.36e-05	0.0281	CbGeAlD
Fluvoxamine—ABCB1—heart—dilated cardiomyopathy	3.26e-05	0.0171	CbGeAlD
